Cargando…
1,25-dihydroxyvitamin D and PTHrP mediated malignant hypercalcemia in a seminoma
BACKGROUND: Seminomas have been rarely associated with malignant hypercalcemia. The responsible mechanism of hypercalcemia in this setting has been described to be secondary to 1,25-dihydroxyvitamin D secretion. The relationship with PTHrP has not been determined or studied. The aim of this study is...
Autores principales: | Rodríguez-Gutiérrez, René, Zapata-Rivera, Maria Azucena, Quintanilla-Flores, Dania Lizeth, Camara-Lemarroy, Carlos Rodrigo, Lavalle-Gonzalez, Fernando Javier, González-González, José Gerardo, Villarreal-Pérez, Jesús Zacarías |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991903/ https://www.ncbi.nlm.nih.gov/pubmed/24721620 http://dx.doi.org/10.1186/1472-6823-14-32 |
Ejemplares similares
-
SAT-153 PTHrP Mediated Hypercalcemia
por: Arguello, Mingxue
Publicado: (2020) -
PTHrP and breast cancer: more than hypercalcemia and bone metastases
por: Boras-Granic, Kata, et al.
Publicado: (2012) -
SAT-LB63 A Case of PTHrP-Negative Hypercalcemia of Malignancy
por: Murati, Jonila, et al.
Publicado: (2020) -
Leukocytosis and PTHrP-Mediated Hypercalcemia: Ominous Signs in an Indolent Thyroid Nodule
por: Gerwer, Johanna Elizabeth, et al.
Publicado: (2021) -
Development of a PTHrP Chemiluminescent Immunoassay to Assess Humoral Hypercalcemia of Malignancy
por: Ashrafzadeh-Kian, Susan Louise, et al.
Publicado: (2021)